We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$4.11B
1-Year Est. Return
26.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
+26.03%
3 Year Est. Return
+55.81%
5 Year Est. Return
+76.4%
10 Year Est. Return
+190.66%
AUM
$8.36B
AUM Growth
-$1.11B
(-12%)
Cap. Flow
-$2.23B
Cap. Flow
% of AUM
-26.73%
Top 10 Holdings %
Top 10 Hldgs %
14.55%
Holding
1,631
New
393
Increased
241
Reduced
303
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$83.4M |
| 2 |
Trip.com Group
TCOM
|
+$77.5M |
| 3 |
Expedia Group
EXPE
|
+$77.4M |
| 4 |
FirstEnergy
FE
|
+$56M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$53.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$89.1M |
| 2 |
Booking.com
BKNG
|
+$62.6M |
| 3 |
Abbott
ABT
|
+$56.3M |
| 4 |
AbbVie
ABBV
|
+$55.7M |
| 5 |
Teradata
TDC
|
+$54.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.86% |
| 2 | Consumer Discretionary | 10.21% |
| 3 | Technology | 8.48% |
| 4 | Communication Services | 8.05% |
| 5 | Healthcare | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Materion
MTRN
$5.22B
| $364K | ﹤0.01% |
+11,790
| New | +$342K |
|
|
LSI
702
DELISTED
LSI CORPORATION
LSI
| $364K | ﹤0.01% |
33,000
-478,091
| -94% | -$4.07M |
|
703
Goldman Sachs
GS
$277B
| $363K | ﹤0.01% |
2,046
-2,446
| -54% | -$403K |
|
704
Orthofix Medical
OFIX
$352M
| $363K | ﹤0.01% |
+15,929
| New | +$333K |
|
|
KKD
705
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $363K | ﹤0.01% |
+18,769
| New | +$424K |
|
|
URS
706
DELISTED
URS CORP
URS
| $361K | ﹤0.01% |
+6,807
| New | +$358K |
|
707
CALL
Crown Castle
CCI
$31.4B
| $360K | ﹤0.01% |
4,900
-2,400
| -33% | -$178K |
|
|
LEAF
708
DELISTED
Leaf Group Ltd.
LEAF
| $354K | ﹤0.01% |
30,874
+23,136
| +299% | +$249K |
|
|
GDP
709
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
| $352K | ﹤0.01% |
+20,663
| New | +$443K |
|
710
CALL
Verizon
VZ
$201B
| $348K | ﹤0.01% |
7,100
-5,300
| -43% | -$261K |
|
|
RJET
711
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
| $345K | ﹤0.01% |
32,331
-5,703
| -15% | -$61.9K |
|
712
Stratasys
SSYS
$701M
| $344K | ﹤0.01% |
+2,552
| New | +$295K |
|
|
DO
713
DELISTED
Diamond Offshore Drilling
DO
| $344K | ﹤0.01% |
+6,041
| New | +$364K |
|
|
FISV
714
PUT
Fiserv Inc
FISV
$26.2B
| $343K | ﹤0.01% |
+11,600
| New | +$313K |
|
715
PUT
Intel
INTC
$575B
| $343K | ﹤0.01% |
13,200
-18,700
| -59% | -$452K |
|
716
CALL
Celldex Therapeutics
CLDX
$3.06B
| $342K | ﹤0.01% |
+940
| New | +$362K |
|
717
PUT
Clearfield
CLFD
$416M
| $342K | ﹤0.01% |
+16,900
| New | +$282K |
|
|
KEM
718
DELISTED
KEMET Corporation
KEM
| $342K | ﹤0.01% |
+60,640
| New | +$336K |
|
719
Flowers Foods
FLO
$1.29B
| $340K | ﹤0.01% |
15,875
-37,180
| -70% | -$839K |
|
|
MTSN
720
DELISTED
MATTSON TECHNOLOGY INC
MTSN
| $339K | ﹤0.01% |
+123,450
| New | +$331K |
|
|
721
CALL
Teradata
TDC
$2.72B
| $338K | ﹤0.01% |
7,400
-2,500
| -25% | -$113K |
|
722
Red Robin
RRGB
$137M
| $337K | ﹤0.01% |
+4,586
| New | +$347K |
|
|
AGN
723
PUT
DELISTED
Allergan plc
AGN
| $337K | ﹤0.01% |
+2,000
| New | +$313K |
|
724
CALL
Lowe's Companies
LOW
$109B
| $333K | ﹤0.01% |
+6,700
| New | +$326K |
|
725
Viavi Solutions
VIAV
$8.57B
| $332K | ﹤0.01% |
+44,843
| New | +$341K |
|
Similar funds
DS
GCC
BHC
BB
DWP
PL
JIM
FMII
Highbridge Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Highbridge Capital Management held 1,631 positions worth $8.36B, down 12% from $9.47B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Highbridge Capital Management withdrew a net $2.23B in Q4 2013, closing 606 positions and reducing 303 holdings. Its most notable exit was AbbVie, an estimated $55.7M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 41% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Highbridge Capital Management opened a new position in Quest Diagnostics worth $43.3M.
- Highbridge Capital Management's largest Q4 2013 buy was Quest Diagnostics: 809,031 shares worth $43.3M.
- Highbridge Capital Management added most to Apple in Q4 2013, an estimated $83.4M increase.
- Highbridge Capital Management's biggest Q4 2013 reduction was VMware, Inc, cutting an estimated $89.1M.
- Highbridge Capital Management fully exited AbbVie in Q4 2013, selling an estimated $55.7M.
- Highbridge Capital Management's ten largest holdings make up 15% of its $8.36B portfolio in Q4 2013.
- Highbridge Capital Management opened 393 new positions and closed 606 in Q4 2013.
- Highbridge Capital Management's portfolio value fell 12% quarter-over-quarter to $8.36B.
Based on Highbridge Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.